Kestra Medical Technologies, Ltd.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 21 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | +21.5% | +27.1% | +15.1% | +2.6% | +14.2% | +12.4% | +16.5% | +8.8% | +16.6% | +8.1% | – | |
| – | – | +17.0% | -0.9% | +3.5% | -3.8% | +12.4% | +9.6% | +5.9% | +4.5% | +11.2% | +4.0% | – | |
| – | – | +58.7% | +200.6% | +38.8% | +12.3% | +16.6% | +16.0% | +29.1% | +13.0% | +21.5% | +11.6% | – | |
| – | -23.1% | +2.3% | -10.9% | +3.1% | -4.4% | +60.6% | -25.7% | +21.9% | +1.9% | +13.3% | +20.6% | – | |
| – | – | +4.9% | +7.3% | +11.6% | +10.9% | +112.1% | -33.2% | +13.6% | +11.5% | +15.7% | -2.1% | – | |
| – | +69.5% | +4.4% | +4.1% | +10.3% | +8.7% | +105.7% | -32.4% | +14.4% | +10.4% | +15.4% | +0.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +94.9% | +17.2% | -3.2% | -25.2% | +27.2% | -1.3% | +8.6% | -0.6% | -0.6% | -2.4% | +4.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -75.4% | -292.9% | – | +14.3% | +125.0% | +466.7% | -67.6% | +3.0% | +2.9% | +448.6% | -74.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.